Navigation Links
Top Belgian Cancer Center Becomes First in Country to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
Date:2/2/2009

LEUVEN, Belgium, Feb. 2 /PRNewswire-FirstCall/ -- A 74-year-old prostate cancer patient has become the first person in Belgium to be treated using a new, faster form of radiotherapy that extends more advanced care to more patients. The University Hospital of Leuven delivered the faster treatment using RapidArc radiotherapy technology from Varian Medical Systems (NYSE: VAR).

The patient, a retired military aircraft engineer from Kortenberg near Leuven, said he was pleased to be the country's first to receive this advanced form of image-guided intensity modulated radiotherapy (IMRT). By coincidence, his older brother was also treated for prostate cancer at the hospital two years ago, receiving a successful course of conventional IMRT.

"This patient is now feeling very well and he is very proud of being number one in Belgium," says Dr. Karin Haustermans, head of the Department of Oncology. "We are identifying patients for whom RapidArc is a beneficial treatment and we have been very pleased with the early results. Not everyone will be treated in this way but it appears to have major advantages in speed and precision for many of our prostate cancer patients."

Frank Van den Heuvel, director of physics, believes RapidArc will enable the hospital to bring down standard treatment slots from 12 minutes to ten minutes, enabling six patients to be treated per hour rather than five. "This is an entirely new technique for us so early treatments will inevitably take a little longer but once it becomes a part of our routine I believe we can achieve these targets," he said.

Prior to starting RapidArc treatments, research physicist Wouter Crijns carried out a series of tests revealing that RapidArc treatments could offer five significant benefits over and above conventional IMRT treatments. Along with time-savings he identified an improvement in sparing nearby organs at risk from being affected by the radiation, an ability to boost the dose from 74 to 78 Gy while achieving a 30% reduction in 'monitor units' used during treatment, and an ability to tighten margins from 1cm to 0.7cm because of less prostate motion during the shorter treatment. In addition, patient comfort is improved because the time they need to lie on the treatment table is shortened considerably.

"The team at Leuven has done a great job in introducing RapidArc treatments so quickly and becoming among the first in Europe to begin treatments using this technique," said Vincent Ronfle, Varian's regional sales manager. "This hospital is well-known for its innovative approach and technical choices and it has been quick to implement an advanced treatment technique which improves quality while saving time."

The University Hospital of Leuven treats up to 200 patients per day on five Varian Clinac(R) linear accelerators. The hospital was one of the earliest in Europe to introduce IMRT treatments and the technique is now used routinely for prostate, head & neck, oesophagus and rectal cancer treatments. As the hospital becomes more familiar with the technique, RapidArc image-guided IMRT treatments will gradually be introduced for indications other than prostate cancer.

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Aggressive Treatment Effective in Kids Brain Cancer
2. Physics, Math Provide Clues to Unraveling Cancer
3. Smithfield Foods Lean Generation(R) Deli Partnership with National Breast Cancer Foundation Celebrates $135,000 Contribution
4. Automated screening process may eventually reduce additional breast cancer surgeries
5. Variations in Gene DNA Boost Drinkers Cancer Risk
6. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
7. Oncogene inhibits tumor suppressor to promote cancer: Study links B-RAF and LKB1
8. Skin color studies on tadpoles lead to cancer advance
9. Gene mutations increase risk for aggressive prostate cancer
10. Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection
11. The Pancreatic Cancer Research and Education Act Addresses the Astounding Mortality of the Fourth Leading Cause of Cancer Death in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) continues ... healthcare organizations to promote diabetes education at the World Diabetes Day observance. The ... speakers from around the Commonwealth of Pennsylvania. Speakers included Dr. Renu Joshi ...
(Date:12/10/2016)... (PRWEB) , ... December 10, 2016 , ... When faced ... worried about germs spreading from the seat to her body, and contamination of children ... and effective way to solve this problem that many people face. , The patent-pending ...
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... planning assistance from offices in Pasco and Richland, is initiating a charity drive ... serious injuries resulting from a recent automobile collision. , On October 29th ...
(Date:12/9/2016)... Cincinnati, Ohio (PRWEB) , ... December 09, 2016 ... ... production of miniature, folded, pharmaceutical inserts and outserts. As a means of ... This addition will enable Flottman to individually code professional inserts (PIs) and ...
(Date:12/9/2016)... ... 2016 , ... The Justin Veatch Fund announced Thursday that ... film Whispering Spirits and its discussion guide for use by all of ... in the war against teen drug abuse. NCADD is the oldest anti-addiction advocacy ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Australia Ophthalmic Lasers Market Outlook to 2022 Summary ... to 2022", provides key market data on the Australia ... of US dollars, volume (in units) and average prices ... and YAG Lasers. The report also provides company ... market segements, and global corporate-level profiles of the key ...
(Date:12/8/2016)... Dec. 8, 2016  The global biosurgery market is ... the forecast period of 2016 to 2021. The market ... from USD 18.21 billion in 2016. The market is ... of sports related injuries and spinal problems, increasing clearance ... of effective blood loss management. In this ...
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... share of the market in 2016 and is expected ... be attributed to a large number of surgical procedures ... the largest share in the patient temperature management market.) ... as reducing loss of blood during surgeries, lowering the ...
Breaking Medicine Technology: